FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4210443505> ?p ?o ?g. }

• W4210443505 endingPage "28" @default.
• W4210443505 startingPage "17" @default.
• W4210443505 abstract "Epidermal growth factor receptor (EGFR) is the primary target for the treatment of colorectal cancer, the third most diagnosed cancer worldwide. In recent years, regulatory changes have facilitated the approval of biosimilars aimed to bring more access to biologics to patients. However, it has also expended the requirements of non-clinical characterisation data using state-of-the-art and orthogonal methodologies to demonstrate similarity between proposed biologic and its reference medicinal product (RMP). The current study was aimed to develop a stable CHO-S cell line producing panitumumab biosimilar candidate, P-mAb, a fully human IgG2 anti-EGFR monoclonal antibody and assess its physicochemical and functional similarity with RMP, Vectibix. The single-cell clone from stably transfected CHO-S cell pools was used for the production of P-mAb. This was followed by purification and comparative physicochemical and biological characterisation of P-mAb and RMP using SDS-PAGE, LC/MS, MALDI, MS/MS, CD spectrometry, DSF, SAXS, ITF, MTT assay and binding affinity. SAXS and MST assays are being used for first time in biosimilarity analysis of therapeutic monoclonal antibody. The results of structural and functional analysis of anti-EGFR P-mAb, produced by stable CHO-S cell line revealed high similarity between P-mAb and RMP, vectibix, thus providing the scientific basis of its potential for therapeutic applications." @default.
• W4210443505 created "2022-02-08" @default.
• W4210443505 creator A5002554721 @default.
• W4210443505 creator A5014188641 @default.
• W4210443505 creator A5022660393 @default.
• W4210443505 creator A5023450312 @default.
• W4210443505 creator A5037432950 @default.
• W4210443505 creator A5081288778 @default.
• W4210443505 creator A5082875201 @default.
• W4210443505 date "2022-02-03" @default.
• W4210443505 modified "2023-10-02" @default.
• W4210443505 title "Evaluation of physicochemical and functional similarity of a new CHO derived anti-EGFR antibody P-mAb to its reference medicinal product" @default.
• W4210443505 cites W1889987954 @default.
• W4210443505 cites W1900055019 @default.
• W4210443505 cites W1927128110 @default.
• W4210443505 cites W1965052190 @default.
• W4210443505 cites W1974302168 @default.
• W4210443505 cites W1974887619 @default.
• W4210443505 cites W1989308735 @default.
• W4210443505 cites W2005157268 @default.
• W4210443505 cites W2019195072 @default.
• W4210443505 cites W2027783748 @default.
• W4210443505 cites W2046997403 @default.
• W4210443505 cites W2057337576 @default.
• W4210443505 cites W2065849320 @default.
• W4210443505 cites W2100837269 @default.
• W4210443505 cites W2114918609 @default.
• W4210443505 cites W2131413118 @default.
• W4210443505 cites W2146103350 @default.
• W4210443505 cites W2147873693 @default.
• W4210443505 cites W2151046736 @default.
• W4210443505 cites W2156670712 @default.
• W4210443505 cites W2172181172 @default.
• W4210443505 cites W2409420104 @default.
• W4210443505 cites W2567289819 @default.
• W4210443505 cites W2606699184 @default.
• W4210443505 cites W2737050261 @default.
• W4210443505 cites W2790763558 @default.
• W4210443505 cites W2794416238 @default.
• W4210443505 cites W2915483287 @default.
• W4210443505 cites W2982208570 @default.
• W4210443505 cites W2995437173 @default.
• W4210443505 cites W3009963727 @default.
• W4210443505 cites W4385789423 @default.
• W4210443505 doi "https://doi.org/10.1080/21691401.2022.2028284" @default.
• W4210443505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35109731" @default.
• W4210443505 hasPublicationYear "2022" @default.
• W4210443505 type Work @default.
• W4210443505 citedByCount "2" @default.
• W4210443505 countsByYear W42104435052023 @default.
• W4210443505 crossrefType "journal-article" @default.
• W4210443505 hasAuthorship W4210443505A5002554721 @default.
• W4210443505 hasAuthorship W4210443505A5014188641 @default.
• W4210443505 hasAuthorship W4210443505A5022660393 @default.
• W4210443505 hasAuthorship W4210443505A5023450312 @default.
• W4210443505 hasAuthorship W4210443505A5037432950 @default.
• W4210443505 hasAuthorship W4210443505A5081288778 @default.
• W4210443505 hasAuthorship W4210443505A5082875201 @default.
• W4210443505 hasBestOaLocation W42104435051 @default.
• W4210443505 hasConcept C150903083 @default.
• W4210443505 hasConcept C159654299 @default.
• W4210443505 hasConcept C170493617 @default.
• W4210443505 hasConcept C175656101 @default.
• W4210443505 hasConcept C185592680 @default.
• W4210443505 hasConcept C203014093 @default.
• W4210443505 hasConcept C2778332735 @default.
• W4210443505 hasConcept C2779438470 @default.
• W4210443505 hasConcept C2779998722 @default.
• W4210443505 hasConcept C502942594 @default.
• W4210443505 hasConcept C54009773 @default.
• W4210443505 hasConcept C542903549 @default.
• W4210443505 hasConcept C54355233 @default.
• W4210443505 hasConcept C552990157 @default.
• W4210443505 hasConcept C55493867 @default.
• W4210443505 hasConcept C59491497 @default.
• W4210443505 hasConcept C70721500 @default.
• W4210443505 hasConcept C81089528 @default.
• W4210443505 hasConcept C81885089 @default.
• W4210443505 hasConcept C86803240 @default.
• W4210443505 hasConcept C98274493 @default.
• W4210443505 hasConceptScore W4210443505C150903083 @default.
• W4210443505 hasConceptScore W4210443505C159654299 @default.
• W4210443505 hasConceptScore W4210443505C170493617 @default.
• W4210443505 hasConceptScore W4210443505C175656101 @default.
• W4210443505 hasConceptScore W4210443505C185592680 @default.
• W4210443505 hasConceptScore W4210443505C203014093 @default.
• W4210443505 hasConceptScore W4210443505C2778332735 @default.
• W4210443505 hasConceptScore W4210443505C2779438470 @default.
• W4210443505 hasConceptScore W4210443505C2779998722 @default.
• W4210443505 hasConceptScore W4210443505C502942594 @default.
• W4210443505 hasConceptScore W4210443505C54009773 @default.
• W4210443505 hasConceptScore W4210443505C542903549 @default.
• W4210443505 hasConceptScore W4210443505C54355233 @default.
• W4210443505 hasConceptScore W4210443505C552990157 @default.
• W4210443505 hasConceptScore W4210443505C55493867 @default.
• W4210443505 hasConceptScore W4210443505C59491497 @default.
• W4210443505 hasConceptScore W4210443505C70721500 @default.
• W4210443505 hasConceptScore W4210443505C81089528 @default.

• next